PMID- 35453042 OWN - NLM STAT- MEDLINE DCOM- 20220504 LR - 20220701 IS - 1525-5069 (Electronic) IS - 1525-5050 (Linking) VI - 130 DP - 2022 May TI - Minimum clinically important difference (MCID) of the personal impact of epilepsy scale (PIES). PG - 108691 LID - S1525-5050(22)00140-8 [pii] LID - 10.1016/j.yebeh.2022.108691 [doi] AB - INTRODUCTION: The Personal Impact of Epilepsy Scale (PIES) assesses patient functional status in subscales of (1) seizure impact, (2) medication effects, (3) mood & social status, and (4) overall quality of life. This study was designed to determine the Minimal Clinically Important Change (MCID) in PIES subscale and total scores that demonstrate improvement. METHODS: To ascertain the correspondence of PIES score change and clinical status change (improved, same, worse) in each PIES subscale and total score, we used two distinct retrospective anchor-based assessments of clinical status (patient self-assessment and trained rater assessment) across two clinic visits. Mean PIES scores were compared between clinical status groups, controlling for days between visits and initial clinical status. Personal Impact of Epilepsy Scale score change was quantified for each group to determine MCID. A small prospective proof-of-concept study was conducted in a separate subject group. RESULTS: Patient self-report anchor analysis demonstrated lower (better) PIES scores in the "improved" group vs the "worse" group on the mood & social subscale (p < .001) and total score (p = .002), with a similar trend on the seizure subscale (p = 0.056). Clinical rater anchor analysis demonstrated lower PIES scores in the "improved" vs "worse" group in the mood & social subscale (p = .029) and a trend in total score (p = .082). For the "improved" group, the reduction in PIES scores between visits averaged across both anchor analyses was 8.14% for subscales and 8.67% for total score. DISCUSSION/CONCLUSION: Reduction of 8% on a PIES subscale or total score indicates meaningful improvement in patient clinical status, and is designated the MCID for this instrument. Personal Impact of Epilepsy Scale can be useful in day-to-day clinical care and as an outcome metric in clinical research. CI - Copyright (c) 2022 Elsevier Inc. All rights reserved. FAU - Martz, Gabriel AU - Martz G AD - Hartford HealthCare, 85 Seymour St, Hartford, CT 06102, United States; Norton Neuroscience Institute, 4915 Norton Healthcare Blvd, Louisville, KY 40241, United States. Electronic address: Gabriel.Martz@hhchealth.org. FAU - Fisher, Robert S AU - Fisher RS AD - Stanford University School of Medicine, 213 Quarry Rd, Palo Alto, CA 94304, United States. Electronic address: Robert.Fisher@Stanford.edu. FAU - Folley, Bradley AU - Folley B AD - Norton Neuroscience Institute, 4915 Norton Healthcare Blvd, Louisville, KY 40241, United States. FAU - Panza, Gregory A AU - Panza GA AD - Hartford HealthCare, 85 Seymour St, Hartford, CT 06102, United States. FAU - Ando, Fumika AU - Ando F AD - Hartford HealthCare, 85 Seymour St, Hartford, CT 06102, United States. FAU - McEachern, Corey AU - McEachern C AD - Norton Neuroscience Institute, 4915 Norton Healthcare Blvd, Louisville, KY 40241, United States. FAU - Blinn, Alma AU - Blinn A AD - Norton Neuroscience Institute, 4915 Norton Healthcare Blvd, Louisville, KY 40241, United States. FAU - Cramer, Joyce A AU - Cramer JA AD - Consultant, 2207 Bancroft St., Houston, TX 77027, United States; Yale University School of Medicine, 333 Cedar St, New Haven, CT 06510, United States. Electronic address: Joyce.Cramer@gmail.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220419 PL - United States TA - Epilepsy Behav JT - Epilepsy & behavior : E&B JID - 100892858 SB - IM MH - *Epilepsy/diagnosis MH - Humans MH - Prospective Studies MH - *Quality of Life MH - Retrospective Studies MH - Seizures MH - Surveys and Questionnaires OTO - NOTNLM OT - Epilepsy OT - Functional status OT - MCID OT - Quality of life OT - Seizures EDAT- 2022/04/23 06:00 MHDA- 2022/05/06 06:00 CRDT- 2022/04/22 20:14 PHST- 2022/01/17 00:00 [received] PHST- 2022/03/30 00:00 [revised] PHST- 2022/03/30 00:00 [accepted] PHST- 2022/04/23 06:00 [pubmed] PHST- 2022/05/06 06:00 [medline] PHST- 2022/04/22 20:14 [entrez] AID - S1525-5050(22)00140-8 [pii] AID - 10.1016/j.yebeh.2022.108691 [doi] PST - ppublish SO - Epilepsy Behav. 2022 May;130:108691. doi: 10.1016/j.yebeh.2022.108691. Epub 2022 Apr 19.